[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  ALTEOGEN Inc. ALTEOGEN Inc. gains EU approval for Eylea biosimilar Eyluxvi and is trending higher with positive mentions in the Asia Pacific region. ### About ALTEOGEN Inc. ALTEOGEN Inc. is a biotechnology and pharmaceutical company. ### Insights [#](/topic/$196170kq/insights) - ALTEOGEN Inc. engagements is up XXXXXX% from the previous month. ### Price: $ [#](/topic/$196170kq/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/close.tsv) The price action is likely influenced by the recent positive news regarding patent filings, regulatory approvals, and mentions in the context of top stocks, which may be driving investor interest and potentially increasing the price. **1-Year High**: $XXXXXXX on 2025-09-22 **1-Year Low**: $XXXXXXX on 2024-12-20 ### AltRank: undefined [#](/topic/$196170kq/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/alt_rank.tsv) ALTEOGEN Inc. is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXXXX **1-Year High**: XXXXX on 2024-12-09 **1-Year Low**: XXX on 2025-03-14 ### Galaxy Score: XX [#](/topic/$196170kq/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2024-12-26 **1-Year Low**: X on 2025-09-24 ### Engagements: XX [#](/topic/$196170kq/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXX +52% **1 Month**: XXXXXX +303% **6 Months**: XXXXXX -XX% **1 Year**: XXXXXX +89% **1-Year High**: XXXXXX on 2025-03-14 **1-Year Low**: X on 2024-12-18 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$196170kq/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **6 Months**: XX -XX% **1 Year**: XXX +212% **1-Year High**: XX on 2025-03-18 **1-Year Low**: X on 2024-10-24 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$196170kq/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/contributors_active.tsv) X unique social accounts have posts mentioning ALTEOGEN Inc. in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: X **6 Months**: XX -XX% **1 Year**: XXX +228% **1-Year High**: XX on 2025-03-18 **1-Year Low**: X on 2024-10-24 ### Sentiment: % [#](/topic/$196170kq/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/sentiment.tsv) **Current Value**: % **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XXX% no change **6 Months**: XXX% +12% **1 Year**: XXX% no change **1-Year High**: XXX% on 2024-11-01 **1-Year Low**: XX% on 2025-06-14 ### Market Cap: $undefined [#](/topic/$196170kq/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$196170kq/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXXXXXX on 2024-11-11 **1-Year Low**: $XXXXXXXXXXXXXXXXXX on 2024-12-20 **Top assets mentioned** In the posts about ALTEOGEN Inc. in the last XX hours [Merck & Co., Inc. (MRK)](/topic/$mrk) **Top topics mentioned** In the posts about ALTEOGEN Inc. in the last XX hours [changer](/topic/changer), [south korea](/topic/south-korea), [stocks](/topic/stocks), [kia](/topic/kia), [$000880ks](/topic/$000880ks), [$012450ks](/topic/$012450ks), [$mrk](/topic/$mrk), [stocks healthcare](/topic/stocks-healthcare), [south korean](/topic/south-korean), [safely](/topic/safely), [$8750t](/topic/$8750t) ### Top Social Posts [#](/topic/$196170kq/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Merck created Keytruda Qlex by combining Keytrudas known immune PD-1 checkpoint inhibitor (pembrolizumab) with a form of the enzyme hyaluronidase (berahyaluronidase alfa-pmph) licensed from the South Korean company Alteogen" [X Link](https://x.com/realtahiramin/status/1978588634849685635) [@realtahiramin](/creator/x/realtahiramin) 2025-10-15T22:27Z 14.5K followers, XX engagements "South Korea - Top Stocks - $012450 / Hanwha Aerospace Co Ltd - Favourable (+57 Rangebound) - $017670 / SK Telecom Co Ltd - Favourable (+48 Rangebound) - $009540 / Korea Shipbuilding & Offshore Engineering Co Ltd - Favourable (+47 Trending Higher) - $196170 / Alteogen Inc - Favourable (+45 Trending Higher) - $033780 / KT&G Corp - Favourable (+44 Rangebound) - $000270 / Kia Corp - Favourable (+42 Trending Higher) - $009150 / Samsung Electro-Mechanics - Favourable (+42 Trending Higher) - $329180 / Hyundai Heavy Industries Co Ltd - Favourable (+41 Trending Higher) - $267260 / Hyundai Electric &" [X Link](https://x.com/Darwin_Knows/status/1962677084243001719) [@Darwin_Knows](/creator/x/Darwin_Knows) 2025-09-02T00:40Z XXX followers, XX engagements "🕰 X minutes subcutaneous administration of pembrolizumab every X weeks is a game changer. 💉Berahyaluronidase alfa (MK-5180 Alteogen Inc.) acts as a permeation enhancer that temporarily degrades hyaluronan in the extracellular matrix surrounding the injection area increasing dispersion and enabling subcutaneous administration of pembrolizumab. @EnriquetaFelip brilliantly presented Phase III MK-3475A-D77 trial with simultaneous publication @Annals_Oncology @myESMO #ESMOAmbassadors #ELCC25 #LCSM" [X Link](https://x.com/Tony_Calles/status/1905285069775778172) [@Tony_Calles](/creator/x/Tony_Calles) 2025-03-27T15:45Z 12.1K followers, 6872 engagements "Could ADCs be safely administered subcutaneously - clinical data of a sc ADC (JSKN003) just presented at #SITC2024 with favorable safety - Daiichi entered in a partnership with Alteogen to develop a sc formulation of T-DXd - -" [X Link](https://x.com/PTarantinoMD/status/1856093263175852396) [@PTarantinoMD](/creator/x/PTarantinoMD) 2024-11-11T21:54Z 29.4K followers, 11K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ALTEOGEN Inc. gains EU approval for Eylea biosimilar Eyluxvi and is trending higher with positive mentions in the Asia Pacific region.
ALTEOGEN Inc. is a biotechnology and pharmaceutical company.
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by the recent positive news regarding patent filings, regulatory approvals, and mentions in the context of top stocks, which may be driving investor interest and potentially increasing the price.
1-Year High: $XXXXXXX on 2025-09-22
1-Year Low: $XXXXXXX on 2024-12-20
AltRank 24-Hour Time-Series Raw Data
ALTEOGEN Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2024-12-09
1-Year Low: XXX on 2025-03-14
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2024-12-26
1-Year Low: X on 2025-09-24
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +52%
1 Month: XXXXXX +303%
6 Months: XXXXXX -XX%
1 Year: XXXXXX +89%
1-Year High: XXXXXX on 2025-03-14
1-Year Low: X on 2024-12-18
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: XX -XX%
1 Year: XXX +212%
1-Year High: XX on 2025-03-18
1-Year Low: X on 2024-10-24
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning ALTEOGEN Inc. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
6 Months: XX -XX%
1 Year: XXX +228%
1-Year High: XX on 2025-03-18
1-Year Low: X on 2024-10-24
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +12%
1 Year: XXX% no change
1-Year High: XXX% on 2024-11-01
1-Year Low: XX% on 2025-06-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXXX on 2024-11-11
1-Year Low: $XXXXXXXXXXXXXXXXXX on 2024-12-20
Top assets mentioned In the posts about ALTEOGEN Inc. in the last XX hours
Top topics mentioned In the posts about ALTEOGEN Inc. in the last XX hours
changer, south korea, stocks, kia, $000880ks, $012450ks, $mrk, stocks healthcare, south korean, safely, $8750t
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Merck created Keytruda Qlex by combining Keytrudas known immune PD-1 checkpoint inhibitor (pembrolizumab) with a form of the enzyme hyaluronidase (berahyaluronidase alfa-pmph) licensed from the South Korean company Alteogen"
X Link @realtahiramin 2025-10-15T22:27Z 14.5K followers, XX engagements
"South Korea - Top Stocks - $012450 / Hanwha Aerospace Co Ltd - Favourable (+57 Rangebound) - $017670 / SK Telecom Co Ltd - Favourable (+48 Rangebound) - $009540 / Korea Shipbuilding & Offshore Engineering Co Ltd - Favourable (+47 Trending Higher) - $196170 / Alteogen Inc - Favourable (+45 Trending Higher) - $033780 / KT&G Corp - Favourable (+44 Rangebound) - $000270 / Kia Corp - Favourable (+42 Trending Higher) - $009150 / Samsung Electro-Mechanics - Favourable (+42 Trending Higher) - $329180 / Hyundai Heavy Industries Co Ltd - Favourable (+41 Trending Higher) - $267260 / Hyundai Electric &"
X Link @Darwin_Knows 2025-09-02T00:40Z XXX followers, XX engagements
"🕰 X minutes subcutaneous administration of pembrolizumab every X weeks is a game changer. 💉Berahyaluronidase alfa (MK-5180 Alteogen Inc.) acts as a permeation enhancer that temporarily degrades hyaluronan in the extracellular matrix surrounding the injection area increasing dispersion and enabling subcutaneous administration of pembrolizumab. @EnriquetaFelip brilliantly presented Phase III MK-3475A-D77 trial with simultaneous publication @Annals_Oncology @myESMO #ESMOAmbassadors #ELCC25 #LCSM"
X Link @Tony_Calles 2025-03-27T15:45Z 12.1K followers, 6872 engagements
"Could ADCs be safely administered subcutaneously - clinical data of a sc ADC (JSKN003) just presented at #SITC2024 with favorable safety - Daiichi entered in a partnership with Alteogen to develop a sc formulation of T-DXd - -"
X Link @PTarantinoMD 2024-11-11T21:54Z 29.4K followers, 11K engagements
/topic/$196170kq